Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.66 USD | -8.98% | -8.80% | -19.04% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.04% | 1.42B | |
+10.86% | 115B | |
+12.33% | 106B | |
-4.34% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-12.85% | 17.56B | |
-40.50% | 17.32B | |
+6.41% | 14.03B | |
+31.30% | 12.13B |
- Stock Market
- Equities
- AKRO Stock
- News Akero Therapeutics, Inc.
- Morgan Stanley Adjusts Price Target on Akero Therapeutics to $40 From $30, Maintains Equalweight Rating